Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib.

Andrea Sartore-Bianchi; Sara Lonardi; Massimo Aglietta; Cosimo Martino; Fortunato Ciardiello; Silvia Marsoni; Salvatore Siena

doi:10.1001/jamaoncol.2020.0571

Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib.

Andrea Sartore-Bianchi, Sara Lonardi, Massimo Aglietta, Cosimo Martino, Fortunato Ciardiello, Silvia Marsoni, Salvatore Siena

Istituto Oncologico Candiolo

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	927-929
Number of pages	3
Journal	JAMA oncology
Volume	6
DOIs	https://doi.org/10.1001/jamaoncol.2020.0571
Publication status	Published - Jun 1 2020

Keywords

Adult
Aged
80 and over
Antineoplastic Agents
therapeutic use
Central Nervous System Neoplasms
radiotherapy
secondary
surgery
Colorectal Neoplasms
drug therapy
metabolism
mortality
pathology
Drug Resistance
Neoplasm
Female
Humans
Lapatinib
Male
Middle Aged
Protein Kinase Inhibitors
Receptor
ErbB-2
Recurrence
Trastuzumab
Treatment Outcome

Access to Document

10.1001/jamaoncol.2020.0571

Cite this

Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib. / Sartore-Bianchi, Andrea; Lonardi, Sara; Aglietta, Massimo ; Martino, Cosimo; Ciardiello, Fortunato; Marsoni, Silvia; Siena, Salvatore.

In: JAMA oncology, Vol. 6, 01.06.2020, p. 927-929.

Research output: Contribution to journal › Article › peer-review

@article{416a5d36b6bf4e35b5ea3a2ab2b473bb,

title = "Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib.",

keywords = "Adult, Aged, 80 and over, Antineoplastic Agents, therapeutic use, Central Nervous System Neoplasms, radiotherapy, secondary, surgery, Colorectal Neoplasms, drug therapy, metabolism, mortality, pathology, Drug Resistance, Neoplasm, Female, Humans, Lapatinib, Male, Middle Aged, Protein Kinase Inhibitors, Receptor, ErbB-2, Recurrence, Trastuzumab, Treatment Outcome",

author = "Andrea Sartore-Bianchi and Sara Lonardi and Massimo Aglietta and Cosimo Martino and Fortunato Ciardiello and Silvia Marsoni and Salvatore Siena",

year = "2020",

month = jun,

day = "1",

doi = "10.1001/jamaoncol.2020.0571",

language = "Non definita",

volume = "6",

pages = "927--929",

journal = "JAMA oncology",

issn = "2374-2437",

publisher = "American Medical Association",

}

TY - JOUR

T1 - Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib.

AU - Sartore-Bianchi, Andrea

AU - Lonardi, Sara

AU - Aglietta, Massimo

AU - Martino, Cosimo

AU - Ciardiello, Fortunato

AU - Marsoni, Silvia

AU - Siena, Salvatore

PY - 2020/6/1

Y1 - 2020/6/1

KW - Adult

KW - Aged

KW - 80 and over

KW - Antineoplastic Agents

KW - therapeutic use

KW - Central Nervous System Neoplasms

KW - radiotherapy

KW - secondary

KW - surgery

KW - Colorectal Neoplasms

KW - drug therapy

KW - metabolism

KW - mortality

KW - pathology

KW - Drug Resistance

KW - Neoplasm

KW - Female

KW - Humans

KW - Lapatinib

KW - Male

KW - Middle Aged

KW - Protein Kinase Inhibitors

KW - Receptor

KW - ErbB-2

KW - Recurrence

KW - Trastuzumab

KW - Treatment Outcome

U2 - 10.1001/jamaoncol.2020.0571

DO - 10.1001/jamaoncol.2020.0571

M3 - Articolo

VL - 6

SP - 927

EP - 929

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

ER -